These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 34261423)

  • 21. Outcome of hospitalized patients with hematological malignancies and COVID-19 infection in a large urban healthcare trust in the United Kingdom.
    Garnett C; Foldes D; Bailey C; Nesr G; Hui T; Hinton R; Gurung K; Phillips J; Saleem Z; Koshy R; Aduwa E; Colis M; Bimolah R; Katsomitrou V; Arami S; Kagdi H
    Leuk Lymphoma; 2021 Feb; 62(2):469-472. PubMed ID: 33167718
    [No Abstract]   [Full Text] [Related]  

  • 22. Risk of COVID-19 Transmission from Infected Outpatients to Healthcare Workers in an Outpatient Clinic.
    Chung H; Kim EO; Kim SH; Jung J
    J Korean Med Sci; 2020 Dec; 35(50):e431. PubMed ID: 33372425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transfusion of blood products derived from SARS-CoV-2+ donors to patients with hematological malignancies.
    Gambacorti-Passerini C; Ruggeri M; Aroldi A; Piazza R; Mazzi A; De Silvestro G; Krampera M; Lanza F
    Transfus Apher Sci; 2021 Jun; 60(3):103105. PubMed ID: 33637468
    [No Abstract]   [Full Text] [Related]  

  • 24. Increase in the severity of acute malignant hemopathies during the COVID-19 pandemia.
    Franch-Sarto M; Torrent Catarineu A; Ribera Santasusana JM
    Med Clin (Barc); 2020 Sep; 155(6):269-270. PubMed ID: 32600983
    [No Abstract]   [Full Text] [Related]  

  • 25. Improvement in mortality of hospitalized patients with hematological malignancies in the 2nd wave of COVID-19 in the UK: experience of a large London NHS trust.
    Hinton R; Nesr G; Garnett C; Foldes D; McCay JJR; Medland R; Kagdi H; Katsomitrou V; Sim HW; Gandhi S; Parcharidou A; Arami S
    Leuk Lymphoma; 2022 Jan; 63(1):227-230. PubMed ID: 34470547
    [No Abstract]   [Full Text] [Related]  

  • 26. SARS-CoV-2 infection and mortality in pediatric patients with hematological malignancies and solid tumors.
    Aguiar JEAT; Carvalho MAL; Viana SS; Martins-Filho PR; Cipolotti R
    Pediatr Hematol Oncol; 2023 May; 40(4):429-432. PubMed ID: 36094799
    [No Abstract]   [Full Text] [Related]  

  • 27. Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies.
    Greenberger LM; Saltzman LA; Senefeld JW; Johnson PW; DeGennaro LJ; Nichols GL
    Cancer Cell; 2021 Aug; 39(8):1031-1033. PubMed ID: 34331856
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
    Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
    Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).
    Pagano L; Salmanton-García J; Marchesi F; Busca A; Corradini P; Hoenigl M; Klimko N; Koehler P; Pagliuca A; Passamonti F; Verga L; Víšek B; Ilhan O; Nadali G; Weinbergerová B; Córdoba-Mascuñano R; Marchetti M; Collins GP; Farina F; Cattaneo C; Cabirta A; Gomes-Silva M; Itri F; van Doesum J; Ledoux MP; Čerňan M; Jakšić O; Duarte RF; Magliano G; Omrani AS; Fracchiolla NS; Kulasekararaj A; Valković T; Poulsen CB; Machado M; Glenthøj A; Stoma I; Ráčil Z; Piukovics K; Navrátil M; Emarah Z; Sili U; Maertens J; Blennow O; Bergantim R; García-Vidal C; Prezioso L; Guidetti A; Del Principe MI; Popova M; de Jonge N; Ormazabal-Vélez I; Fernández N; Falces-Romero I; Cuccaro A; Meers S; Buquicchio C; Antić D; Al-Khabori M; García-Sanz R; Biernat MM; Tisi MC; Sal E; Rahimli L; Čolović N; Schönlein M; Calbacho M; Tascini C; Miranda-Castillo C; Khanna N; Méndez GA; Petzer V; Novák J; Besson C; Duléry R; Lamure S; Nucci M; Zambrotta G; Žák P; Seval GC; Bonuomo V; Mayer J; López-García A; Sacchi MV; Booth S; Ciceri F; Oberti M; Salvini M; Izuzquiza M; Nunes-Rodrigues R; Ammatuna E; Obr A; Herbrecht R; Núñez-Martín-Buitrago L; Mancini V; Shwaylia H; Sciumè M; Essame J; Nygaard M; Batinić J; Gonzaga Y; Regalado-Artamendi I; Karlsson LK; Shapetska M; Hanakova M; El-Ashwah S; Borbényi Z; Çolak GM; Nordlander A; Dragonetti G; Maraglino AME; Rinaldi A; De Ramón-Sánchez C; Cornely OA;
    J Hematol Oncol; 2021 Oct; 14(1):168. PubMed ID: 34649563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of SARS-CoV-2 infections among patients with end-stage renal disease following facility-wide testing in four outpatient hemodialysis facilities.
    Wilson WW; Bardossy AC; Gable P; Herzig C; Beshearse E; Gualandi N; Sabour S; Brown N; Brown AC; Kutty P; Tobin-D'Angelo M; Lea JP; Apata IW; Novosad S;
    Am J Infect Control; 2021 Oct; 49(10):1318-1321. PubMed ID: 34375701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Management of patients with hematological malignancies in outbreak areas of COVID-19 epidemic: our experience at Wuhan Tongji Hospital].
    Xiao Y; Cao Y; Huang L; Zheng M; Meng FK; Huang W; Li CR; Huang M; Zhang YC; Zhang DH; Deng JN; Meng L; Sun HY; Tang Y; Li DJ; Wan Y; Xu L; Zhou JF
    Zhonghua Xue Ye Xue Za Zhi; 2020 Jul; 41(7):612-614. PubMed ID: 32810973
    [No Abstract]   [Full Text] [Related]  

  • 32. Self-Collected Gargle Lavage Allows Reliable Detection of SARS-CoV-2 in an Outpatient Setting.
    Zander J; Scholtes S; Ottinger M; Kremer M; Kharazi A; Stadler V; Bickmann J; Zeleny C; Kuiper JWP; Hauck CR
    Microbiol Spectr; 2021 Sep; 9(1):e0036121. PubMed ID: 34259547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of COVID 19 on red flag discussions for haematological malignancies within the Belfast trust.
    Waddell D; Benson G
    Ulster Med J; 2021 May; 90(2):77-80. PubMed ID: 34276084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Weathering the storm: COVID-19 infection in patients with hematological malignancies.
    Wang LQ; Tan Su Yin E; Wei GQ; Hu YX; Nagler A; Huang H
    J Zhejiang Univ Sci B; 2020 Dec.; 21(12):921-939. PubMed ID: 33843158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 in Patients with Hematologic Disorders Undergoing Therapy: Perspective of a Large Referral Hematology Center in Rome.
    Girmenia C; Gentile G; Micozzi A; Petrucci L; Malaspina F; Di Prima A; Baldacci E; Bianchi S; Pugliese P; Turriziani O; Antonelli G; Tombolini V; Foà R; Martelli M
    Acta Haematol; 2020; 143(6):574-582. PubMed ID: 32932252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 and haematological malignancy: navigating a narrow strait.
    Rubinstein SM; Warner JL
    Lancet Haematol; 2020 Oct; 7(10):e701-e703. PubMed ID: 32798474
    [No Abstract]   [Full Text] [Related]  

  • 37. COVID-19 and haematology-oncology services.
    The Lancet Haematology
    Lancet Haematol; 2020 Sep; 7(9):e625. PubMed ID: 32853576
    [No Abstract]   [Full Text] [Related]  

  • 38. The management of hematologic malignancies during the COVID-19 pandemic.
    Hus I; Salomon-Perzyński A; Tomasiewicz K; Robak T
    Expert Opin Pharmacother; 2021 Apr; 22(5):565-582. PubMed ID: 33342308
    [No Abstract]   [Full Text] [Related]  

  • 39. Managing patients with hematological malignancies during COVID-19 pandemic.
    Sahu KK; Cerny J
    Expert Rev Hematol; 2020 Aug; 13(8):787-793. PubMed ID: 32580592
    [No Abstract]   [Full Text] [Related]  

  • 40. The outcome ofancy. COVID-19 in patients with hematological malign.
    Yigenoglu TN; Bascı S; Dal MS; Korkmaz S; Turgut B; Altuntas F
    J Med Virol; 2021 Mar; 93(3):1255. PubMed ID: 33064307
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.